Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees.

Documenti analoghi

• Purified envelope glycoproteins from human immunodeficiency virus type 1 variants induce individual, type-specific neutralizing antibodies.
  di: Nara, P L, et al.
  Pubblicazione: (1988)
• Antibody-mediated in vitro neutralization of human immunodeficiency virus type 1 abolishes infectivity for chimpanzees.
  di: Emini, E A, et al.
  Pubblicazione: (1990)
• Challenge of chimpanzees (Pan troglodytes) immunized with human immunodeficiency virus envelope glycoprotein gp120.
  di: Arthur, L O, et al.
  Pubblicazione: (1989)
• Specific cellular immune response and neutralizing antibodies in goats immunized with native or recombinant envelope proteins derived from human T-lymphotropic virus type IIIB and in human immunodeficiency virus-infected men.
  di: Krohn, K, et al.
  Pubblicazione: (1987)
• Mutations in human immunodeficiency virus type 1 gp41 affect sensitivity to neutralization by gp120 antibodies.
  di: Back, N K, et al.
  Pubblicazione: (1993)